JHL Biotech Inc:製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C8285)
◆英語タイトル:JHL Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8285
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
JHL Biotech Inc (JHL Biotech) is a biologic medicines provider. The company offers cell line construction, process development, manufacturing, quality and regulatory services. It offers products such as biosimilar rituximab, biosimilar dornase alfa, biosimilar bevacizumab, biosimilar trastuzuma, biosimilar omalizumab, biosimilar pertuzumab and biosimilar denosumab. JHL Biotech has developed its own proprietary CHO-K1 cell line. The company offers antibody cloning, monoclonal antibody manufacturability and protein engineering, cell line development, cell culture process development, purification process development, formulation development and analytical assays. JHL Biotech also provides full-service contract manufacturing solutions to its partners, from cell line development through commercial active pharmaceutical ingredient manufacturing requirements. The company operates through its research center in Hsinchu, Taiwan; commercial GMP facility in Wuhan, China. JHL Biotech is headquartered in Zhubei, Taiwan.

JHL Biotech Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JHL Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
JHL Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 9
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
JHL Biotech Raises USD45.6 Million in Series C Financing 12
JHL Biotech Raises USD35 Million in Series B Venture Financing 13
JHL Biotech Raises US$10 Million In Venture Financing 15
JHL Biotech Raises Funds Through Venture Financing 16
Private Equity 17
JHL Biotech Raises USD106 Million in Financing 17
Partnerships 19
Sanofi Enters into Agreement with JHL Biotech 19
BioLineRx Enters Into Co-Development Agreement With JHL Biotech 20
JHL Biotech Enters Into Agreement With Selexis For Drug Development 22
Equity Offering 23
JHL Biotech Raises USD80 Million in Private Placement of Shares 23
JHL Biotech to Raise Funds through Private Placement of Shares 24
Debt Offering 25
JHL Biotech Raises USD106 Million in Private Placement of Bonds 25
Acquisition 26
JHL Biotech Acquires 40% Stake in Wuhan-Based Bio-Medical Company for USD6.1 Million 26
JHL Biotech Inc – Key Competitors 27
JHL Biotech Inc – Key Employees 28
JHL Biotech Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Corporate Communications 30
Jun 13, 2018: JHL Biotech Announces Appointment of New Chief Financial Officer 30
Feb 01, 2018: JHL Biotech Shareholders Vote to Voluntary Delist from Taiwan Exchange 31
Jan 01, 2018: JHL Biotech Welcomes New Chief Medical Officer, Rong Chen 32
Dec 11, 2017: JHL Announces Its Proposed Voluntary Delisting from Emerging Stock Market of Taipei Exchange 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
JHL Biotech Inc, Pharmaceuticals & Healthcare, Key Facts 2
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JHL Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JHL Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
JHL Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 9
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
JHL Biotech Raises USD45.6 Million in Series C Financing 12
JHL Biotech Raises USD35 Million in Series B Venture Financing 13
JHL Biotech Raises US$10 Million In Venture Financing 15
JHL Biotech Raises Funds Through Venture Financing 16
JHL Biotech Raises USD106 Million in Financing 17
Sanofi Enters into Agreement with JHL Biotech 19
BioLineRx Enters Into Co-Development Agreement With JHL Biotech 20
JHL Biotech Enters Into Agreement With Selexis For Drug Development 22
JHL Biotech Raises USD80 Million in Private Placement of Shares 23
JHL Biotech to Raise Funds through Private Placement of Shares 24
JHL Biotech Raises USD106 Million in Private Placement of Bonds 25
JHL Biotech Acquires 40% Stake in Wuhan-Based Bio-Medical Company for USD6.1 Million 26
JHL Biotech Inc, Key Competitors 27
JHL Biotech Inc, Key Employees 28
JHL Biotech Inc, Other Locations 29

List of Figures
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JHL Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
JHL Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ JHL Biotech Inc:製薬・医療:M&Aディール及び事業提携情報(JHL Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆